Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,688 | 957 | 99.8% |
| Education | $20.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $5,383 | 462 | $0 (2024) |
| Janssen Biotech, Inc. | $1,355 | 123 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $864.45 | 51 | $0 (2024) |
| Gilead Sciences, Inc. | $829.13 | 64 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $539.64 | 35 | $0 (2024) |
| Merck Sharp & Dohme LLC | $415.98 | 25 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $389.60 | 40 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $242.23 | 10 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $231.85 | 8 | $0 (2022) |
| Ironwood Pharmaceuticals, Inc | $203.97 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,395 | 149 | ABBVIE INC. ($1,034) |
| 2023 | $1,944 | 126 | ABBVIE INC. ($890.81) |
| 2022 | $1,657 | 124 | ABBVIE INC. ($839.79) |
| 2021 | $1,329 | 103 | AbbVie Inc. ($718.47) |
| 2020 | $665.55 | 64 | AbbVie Inc. ($496.03) |
| 2019 | $1,487 | 140 | AbbVie, Inc. ($551.11) |
| 2018 | $1,610 | 118 | AbbVie, Inc. ($496.23) |
| 2017 | $1,621 | 134 | AbbVie, Inc. ($357.18) |
All Payment Transactions
958 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: Gastroenterology | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.23 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $3.46 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.21 | General |
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $118.99 | General |
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: Immunology | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 742 | 800 | $503,158 | $86,323 |
| 2022 | 18 | 760 | 812 | $461,749 | $81,855 |
| 2021 | 18 | 895 | 1,028 | $493,122 | $101,639 |
| 2020 | 16 | 871 | 1,015 | $429,885 | $92,503 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 138 | 138 | $161,500 | $26,376 | 16.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 63 | 63 | $52,164 | $10,608 | 20.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 69 | 69 | $21,735 | $7,408 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 73 | $15,038 | $6,671 | 44.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 92 | 95 | $62,415 | $5,733 | 9.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 45 | 89 | $16,554 | $5,303 | 32.0% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 51 | 52 | $38,480 | $4,316 | 11.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 51 | 51 | $50,439 | $4,191 | 8.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 23 | $11,868 | $3,008 | 25.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 17 | 17 | $14,076 | $2,740 | 19.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 28 | $9,787 | $2,669 | 27.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 33 | 34 | $18,904 | $2,432 | 12.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $15,732 | $2,303 | 14.6% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 12 | 12 | $9,996 | $1,461 | 14.6% |
| 91010 | Study of esophagus to assess movement | Facility | 2023 | 13 | 13 | $2,301 | $589.20 | 25.6% |
| 91037 | Monitoring and recording of esophageal function through nasal tube with electrode | Facility | 2023 | 13 | 13 | $1,729 | $446.52 | 25.8% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Facility | 2023 | 11 | 11 | $440.00 | $68.80 | 15.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 133 | 133 | $156,142 | $23,792 | 15.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 95 | $19,570 | $7,786 | 39.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 70 | 70 | $22,050 | $7,777 | 35.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 41 | 41 | $33,948 | $6,779 | 20.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 58 | 95 | $14,880 | $4,996 | 33.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 87 | 88 | $57,816 | $4,821 | 8.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 48 | 48 | $47,837 | $3,902 | 8.2% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 42 | 42 | $27,919 | $3,596 | 12.9% |
About Dr. Sushil Jain, MD
Dr. Sushil Jain, MD is a Gastroenterology healthcare provider based in Fort Wayne, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649247057.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sushil Jain, MD has received a total of $12,708 in payments from pharmaceutical and medical device companies, with $2,395 received in 2024. These payments were reported across 958 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($12,688).
As a Medicare-enrolled provider, Jain has provided services to 3,268 Medicare beneficiaries, totaling 3,655 services with total Medicare billing of $362,320. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Fort Wayne, IN
- Active Since 03/03/2006
- Last Updated 09/29/2020
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1649247057
Products in Payments
- LINZESS (Drug) $1,267
- STELARA (Biological) $1,001
- Humira (Biological) $694.20
- SKYRIZI (Biological) $666.48
- RINVOQ (Biological) $561.64
- HUMIRA (Biological) $513.84
- Entyvio (Biological) $503.37
- ZENPEP (Drug) $452.87
- REMICADE (Biological) $382.29
- CREON (Drug) $373.39
- VIBERZI (Drug) $324.75
- DUPIXENT (Biological) $312.28
- MAVYRET (Drug) $310.66
- XIFAXAN (Drug) $255.09
- Mavyret (Drug) $253.82
- ENTYVIO (Biological) $232.34
- OCALIVA (Drug) $231.85
- Creon (Drug) $217.51
- DIFICID (Drug) $209.05
- Sucraid (Drug) $160.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fort Wayne
Dr. Efesomwan Aisien, M.d, M.D
Gastroenterology — Payments: $89,557
Dr. Abdo Saad, Md, MD
Gastroenterology — Payments: $59,492
Melissa Garrett, Md, MD
Gastroenterology — Payments: $59,090
Dr. Mariajose Rojas De Leon, Md, MD
Gastroenterology — Payments: $39,782
Dr. Kirsten Weiser, M.d, M.D
Gastroenterology — Payments: $20,935
Dr. David Gutman, Md, Facg, MD, FACG
Gastroenterology — Payments: $13,732